STEATOTIC LIVER DISEASE
Clinical trials for STEATOTIC LIVER DISEASE explained in plain language.
Never miss a new study
Get alerted when new STEATOTIC LIVER DISEASE trials appear
Sign up with your email to follow new studies for STEATOTIC LIVER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells aim to calm liver scarring in first human trial
Disease control Recruiting nowThis study tests a new treatment called RTX001 for people with severe liver scarring (cirrhosis) that has led to complications. RTX001 uses the patient's own immune cells, modified in a lab to reduce inflammation and scarring. The trial will enroll 30 adults to check if the thera…
Matched conditions: STEATOTIC LIVER DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Resolution Therapeutics Limited • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New drug tested in patients with fatty liver and cirrhosis
Knowledge-focused Recruiting nowThis early-stage study tests a single dose of an experimental drug called efimosfermin alfa in 32 adults with fatty liver disease and varying degrees of liver damage. The goal is to see how the drug moves through the body and whether it is safe. Participants must have liver cirrh…
Matched conditions: STEATOTIC LIVER DISEASE
Phase: PHASE1 • Sponsor: GlaxoSmithKline • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC